Evidence map›Paper›PMID 36387971›Full record

ArticleSchizophrenia bulletin open2022

Increased Presynaptic Dopamine Synthesis Capacity Is Associated With Aberrant Dopamine Neuron Activity in the Methylazoxymethanol Acetate Rodent Model Used to Study Schizophrenia-Related Pathologies.

Stephanie M Perez, Hannah B Elam, Daniel J Lodge

Open access · goldAbstract read
In one paragraph

Article in Schizophrenia bulletin open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. GL-II-73, a Positive Allosteric Modulator of α5GABAInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Stephanie M PerezDepartment of Pharmacology and Center for Biomedical Neuroscience, UT Health San Antonio, San Antonio, TX, USA.ORCID https://orcid.org/0000-0002-3258-4456
Hannah B ElamDepartment of Pharmacology and Center for Biomedical Neuroscience, UT Health San Antonio, San Antonio, TX, USA.ORCID https://orcid.org/0000-0002-6106-4011
Daniel J LodgeDepartment of Pharmacology and Center for Biomedical Neuroscience, UT Health San Antonio, San Antonio, TX, USA.
The University of Texas Health Science Center at San Antonio · US

Funding

Regulation of ventral hippocampal system functionR01MH090067 · NIMH · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LODGE, DANIEL · 2010 to 2019
$3.5M
Examining orexinergic modulation of the paraventricular nucleus of the thalamus as a novel therapeutic for PTSD and comorbid psychosisF31MH127890 · NIMH · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ELAM, HANNAH · 2022 to 2023
$43k
BLRD VA I01 BX004646BLRD VA I01 BX004693NIMH NIH HHS F31 MH127890NIMH NIH HHS R01 MH090067
6 · The paper itself

Abstract

Aberrant dopamine system function is thought to contribute to the positive symptoms of schizophrenia. Clinical imaging studies have demonstrated that the largest dopamine abnormality in patients appears to be an increase in presynaptic dopamine activity. Indeed, studies utilizing

Indexed as

autoradiographydopamineMAMschizophreniaventral tegmental area

Identifiers

PMID36387971
PMCPMC9642313
OpenAlexW4307054474

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.